Exosomal circ_0097112 drives icotinib resistance through activating RAF/MAPK signaling in lung adenocarcinoma
Cellular Signalling · 2026-10 · 146 · 112652
DOI: 10.1016/j.cellsig.2026.112652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Ziyuan Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315020, China; Department of Biochemistry and Mo…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Adenocarcinoma of Lung, Lung Neoplasms, RNA, Circular. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ningbo University, Natural Science Foundation of Ningbo Municipality.
Abstract (Originalsprache)
Exosomes serve as critical mediators in driving therapeutic resistance among tumor cells by delivering bioactive molecules, including circular RNAs (circRNAs). Through bioinformatics mining of public databases, we identified circ_0097112 as a circular RNA implicated in icotinib resistance in lung adenocarcinoma (LUAD). Our subsequent experiments revealed that circ_0097112 was specifically upregulated in EGFR-TKI-resistant cells and in their secreted exosomes. To elucidate the functional role of circ_0097112 in EGFR-TKI-resistant lung cancer cells, we conducted in vitro experiments demonstrating that circ_0097112 promotes proliferation and concomitantly suppresses apoptosis in LUAD cells. Confocal microscopy revealed that drug-resistant lung cancer cells encapsulate circ_0097112 within exosomal vesicles and horizontally transfer this cargo to drug-sensitive recipient cells, thereby conferring acquired resistance. To delineate the mechanistic basis by which circ_0097112 confers drug resistance, we integrated bioinformatic prediction with experimental validation, including RNA pull-down and RNA immunoprecipitation assays. Our findings demonstrated that circ_0097112 directly interacts with UPF1 protein to assemble a functional complex, thereby suppressing decay of oncogenic NRAS. This molecular event consequently activates downstream RAF/MAPK signaling, attenuating apoptosis while promoting cellular proliferation and drug resistance. Collectively, this study reveals the pivotal involvement of the circ_0097112/UPF1/NRAS axis in driving EGFR-TKI resistance in LUAD and offers a new theoretical basis for targeting circ_0097112 to reverse EGFR-TKI resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315020, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Health Science Cent…
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China.
- Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang 315020, China. Electronic address: zhouchengwei@nbu.edu.cn.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, China. Electronic address: mengxiaodan@nbu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Ningbo University
- Natural Science Foundation of Ningbo Municipality
Zitieren
APA
Chen, Z., Wang, Y., Xu, Y., Wang, S., Xu, Z., Tang, X., Kang, B., Zhou, C., & Meng, X. (2026). Exosomal circ_0097112 drives icotinib resistance through activating RAF/MAPK signaling in lung adenocarcinoma. Cellular Signalling, 146, 112652. https://doi.org/10.1016/j.cellsig.2026.112652
Vancouver
Chen Z, Wang Y, Xu Y, Wang S, Xu Z, Tang X, et al. Exosomal circ_0097112 drives icotinib resistance through activating RAF/MAPK signaling in lung adenocarcinoma. Cellular Signalling. 2026;146:112652. doi:10.1016/j.cellsig.2026.112652
BibTeX
@article{Chen2026,
author = {Chen, Ziyuan and Wang, Yu and Xu, Yier and Wang, Shuaibin and Xu, Zhiyuan and Tang, Xingping and Kang, Bailamu and Zhou, Chengwei and Meng, Xiaodan},
title = {Exosomal circ_0097112 drives icotinib resistance through activating RAF/MAPK signaling in lung adenocarcinoma},
journal = {Cellular Signalling},
year = {2026},
volume = {146},
pages = {112652},
doi = {10.1016/j.cellsig.2026.112652}
}
EUVIMED